keyword
https://read.qxmd.com/read/37353335/pulmonary-rehabilitation-in-persons-with-copd
#21
JOURNAL ARTICLE
Chris Garvey
Pulmonary rehabilitation (PR) is a high-value intervention for persons with COPD and other chronic lung diseases. It is associated with improvement in exercise capacity, dyspnea, health-related quality of life, and depression as well as a reduction in hospitalization and improved survival when PR follows COPD-related hospitalizations. PR is underused in the United States and other countries despite strong evidence of both clinical effectiveness and cost-effectiveness. Additional challenges include a lack of equitable reimbursement and poor access, particularly in rural settings...
July 2023: Respiratory Care
https://read.qxmd.com/read/37305790/mobile-heath-applications-for-self-management-in-chronic-lung-disease-a-systematic-review
#22
REVIEW
Shirley Quach, Wade Michaelchuk, Adam Benoit, Ana Oliveira, Tara L Packham, Roger Goldstein, Dina Brooks
UNLABELLED: Integration of mobile health (mHealth) applications (apps) into chronic lung disease management is becoming increasingly popular. MHealth apps may support adoption of self-management behaviors to assist people in symptoms control and quality of life enhancement. However, mHealth apps' designs, features, and content are inconsistently reported, making it difficult to determine which were the effective components. Therefore, this review aims to summarize the characteristics and features of published mHealth apps for chronic lung diseases...
2023: Network Modeling and Analysis in Health Informatics and Bioinformatics
https://read.qxmd.com/read/37304093/critical-air-pollutant-assessments-and-health-effects-attributed-to-pm-2-5-during-and-after-covid-19-lockdowns-in-iran-application-of-airq-models
#23
JOURNAL ARTICLE
Safiye Ghobakhloo, Amir Hossein Khoshakhlagh, Gholam Reza Mostafaii, Kai-Jen Chuang, Agnieszka Gruszecka-Kosowska, Pariya Hosseinnia
OBJECTIVES: The aim of this study was to evaluate changes in air quality index (AQI) values before, during, and after lockdown, as well as to evaluate the number of hospitalizations due to respiratory and cardiovascular diseases attributed to atmospheric PM2.5 pollution in Semnan, Iran in the period from 2019 to 2021 during the COVID-19 pandemic. METHODS: Daily air quality records were obtained from the global air quality index project and the US Environmental Protection Administration (EPA)...
2023: Frontiers in Public Health
https://read.qxmd.com/read/37153221/machine-learning-for-screening-of-at-risk-mild-and-moderate-copd-patients-at-risk-of-fev-1-decline-results-from-copdgene-and-spiromics
#24
JOURNAL ARTICLE
Jennifer M Wang, Wassim W Labaki, Susan Murray, Fernando J Martinez, Jeffrey L Curtis, Eric A Hoffman, Sundaresh Ram, Alexander J Bell, Craig J Galban, MeiLan K Han, Charles Hatt
Purpose: The purpose of this study was to train and validate machine learning models for predicting rapid decline of forced expiratory volume in 1 s (FEV1 ) in individuals with a smoking history at-risk-for chronic obstructive pulmonary disease (COPD), Global Initiative for Chronic Obstructive Lung Disease (GOLD 0), or with mild-to-moderate (GOLD 1-2) COPD. We trained multiple models to predict rapid FEV1 decline using demographic, clinical and radiologic biomarker data. Training and internal validation data were obtained from the COPDGene study and prediction models were validated against the SPIROMICS cohort...
2023: Frontiers in Physiology
https://read.qxmd.com/read/37139140/non-invasive-detection-of-severe-ph-in-lung-disease-using-magnetic-resonance-imaging
#25
JOURNAL ARTICLE
Dheyaa Alkhanfar, Krit Dwivedi, Faisal Alandejani, Yousef Shahin, Samer Alabed, Chris Johns, Pankaj Garg, A A Roger Thompson, Alexander M K Rothman, Abdul Hameed, Athanasios Charalampopoulos, Jim M Wild, Robin Condliffe, David G Kiely, Andrew J Swift
INTRODUCTION: Severe pulmonary hypertension (mean pulmonary artery pressure ≥35 mmHg) in chronic lung disease (PH-CLD) is associated with high mortality and morbidity. Data suggesting potential response to vasodilator therapy in patients with PH-CLD is emerging. The current diagnostic strategy utilises transthoracic Echocardiography (TTE), which can be technically challenging in some patients with advanced CLD. The aim of this study was to evaluate the diagnostic role of MRI models to diagnose severe PH in CLD...
2023: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/37088438/efficacy-of-cefiderocol-versus-colistin-containing-regimen-for-treatment-of-bacteremic-ventilator-associated-pneumonia-caused-by-carbapenem-resistant-acinetobacter-baumannii-in-covid-19-patients
#26
JOURNAL ARTICLE
Alessandro Russo, Andrea Bruni, Sara Gullì, Cristian Borrazzo, Angela Quirino, Rosaria Lionello, Francesca Serapide, Eugenio Garofalo, Riccardo Serraino, Francesco Romeo, Nadia Marascio, Giovanni Matera, Federico Longhini, Enrico Maria Trecarichi, Carlo Torti
INTRODUCTION: ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii (CRAB) in patients hospitalized in intensive care units (ICU) is an important and challenging complication, including in COVID-19 patients. Considering the poor lung penetration of most antibiotics, including intravenous colistin due to the poor PK/PD at the infection site, the choice of the best antibiotic regimen is still being debated. METHODS: this was a single-center, observational study conducted from March 2020 to August 2022, including all patients hospitalized consecutively with VAP and concomitant bloodstream infection due to CRAB in the COVID-ICU...
April 21, 2023: International Journal of Antimicrobial Agents
https://read.qxmd.com/read/37012147/differences-in-va-and-non-va-pulmonary-nodules-all-evaluations-are-not-created-equal
#27
JOURNAL ARTICLE
Melissa L New, Erin A Hirsch, William J Feser, Stephen P Malkoski, Kavita Garg, York E Miller, Anna E Baron
BACKGROUND: Indeterminate pulmonary nodules present a common challenge for clinicians who must recommend surveillance or intervention based on an assessed risk of malignancy. PATIENTS AND METHODS: In this cohort study, patients presenting for indeterminate pulmonary nodule evaluation were enrolled at sites participating in the Colorado SPORE in Lung Cancer. They were followed prospectively and included for analysis if they had a definitive malignant diagnosis, benign diagnosis, or radiographic resolution or stability of their nodule for > 2 years...
March 4, 2023: Clinical Lung Cancer
https://read.qxmd.com/read/36969920/time-to-sputum-conversion-in-patients-with-pulmonary-tuberculosis-a-score-to-estimate-the-infectious-period
#28
JOURNAL ARTICLE
Maria Ramirez-Hidalgo, Javier Trujillano-Cabello, Adrià Espluges-Vidal, Mercé Reñé-Reñé, Miguel Santín, Adrián Sánchez-Montalvá, Albert Bernet-Sánchez, Laura Gros-Navés, Miquel Falguera
INTRODUCTION: Patients with pulmonary tuberculosis (PTB) disease and positive sputum cultures are the main source of infection. Culture conversion time is inconsistent and defining the length of respiratory isolation is challenging. The objective of this study is to develop a score to predict the length of isolation period. METHODS: A retrospective study was carried out to evaluated risk factors associated with persistent positive sputum cultures after 4 weeks of treatment in 229 patients with PTB...
May 2023: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
https://read.qxmd.com/read/36949186/enhanced-optimal-parameter-based-nebulizer-design-for-flow-analysis-of-fluticasone-propionate
#29
JOURNAL ARTICLE
Vinoth N, Bhaskara Rao Lokavarapu
A jet nebulizer sprays a fine mist or aerosol directly into the lungs to reduce inflammation, expand airways, and make breathing easier for respiratory patients. Asthma, COPD, emphysema, and cystic fibrosis are treated with jet nebulizers. They are chosen over other nebulizers for their shorter treatment time and wider medication compatibility. For mechanically ventilated patients, jet nebulizers humidify oxygen to provide bronchodilators, antibiotics, and other respiratory medications. Additionally, they treat pneumonia, bronchitis, and other lung infections...
March 22, 2023: AAPS PharmSciTech
https://read.qxmd.com/read/36901843/modeling-of-respiratory-diseases-evolving-with-fibrosis-from-organoids-derived-from-human-pluripotent-stem-cells
#30
REVIEW
Irene Chamorro-Herrero, Alberto Zambrano
Respiratory disease is one of the leading causes of morbidity and mortality worldwide. There is no cure for most diseases, which are treated symptomatically. Hence, new strategies are required to deepen the understanding of the disease and development of therapeutic strategies. The advent of stem cell and organoid technology has enabled the development of human pluripotent stem cell lines and adequate differentiation protocols for developing both airways and lung organoids in different formats. These novel human-pluripotent-stem-cell-derived organoids have enabled relatively accurate disease modeling...
February 23, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36849192/evaluation-of-an-implementation-package-to-deliver-the-copd-care-service
#31
JOURNAL ARTICLE
Edward Portillo, Molly Lehmann, Timothy Hagen, Martha Maurer, Jordyn Kettner, Sonia Bhardwaj, David Goodrich, M Shawn McFarland, Natasha Virrueta, Blake Henderson, Jen Birstler, Michelle A Chui
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide and is estimated to be the leading cause of death in the next 15 years. Patients with COPD suffer from persistent chronic cough, sputum production and exacerbations leading to deteriorating lung function, worsening quality of life and loss of independence. While evidence-based interventions exist to improve the well-being of patients with COPD, incorporation of these interventions into routine clinical care is challenging...
February 2023: BMJ Open Quality
https://read.qxmd.com/read/36796249/the-relationship-between-dyspnea-related-kinesiophobia-and-physical-activity-in-people-with-copd-cross-sectional-survey-and-mediated-moderation-analysis
#32
JOURNAL ARTICLE
Jingjing Wang, Chenxiao Bai, Zeyi Zhang, Ou Chen
BACKGROUND: Changing the behavior of physical activity (PA) in COPD patients remains a challenge, because this population faces the same barriers to PA as the general population, as well as disease-specific barriers, especially dyspnea-related kinesiophobia. OBJECTIVES: This study aimed to assess the status of dyspnea-related kinesiophobia in people with COPD, and investigate its impact on PA levels, further examine the mediated moderation effects of exercise perception and social support on this relationship...
February 14, 2023: Heart & Lung: the Journal of Critical Care
https://read.qxmd.com/read/36724677/eligibility-to-lung-cancer-screening-among-staffs-of-a-university-hospital-a-large-cross-sectional-survey
#33
JOURNAL ARTICLE
Emmanuel Grolleau, Julie de Bermont, Flavien Devun, David Pérol, Véronique Lacoste, Loïc Delastre, Fanny Fleurisson, Gilles Devouassoux, Jean-François Mornex, François Cotton, Marie Darrason, Martin Tammemagi, Sébastien Couraud
INTRODUCTION: Implementation of Lung cancer screening (LCS) programs is challenging. The ILYAD study objectives is to evaluate communication methods to improve participation rate among the Lyon University Hospital employees. In this first part of the study, we aimed to determinate the number of eligible individuals among our population of employees. METHOD: In November 2020, we conducted a questionnaire based cross sectional survey among the Lyon University Hospital employees (N = 26,954)...
November 2, 2022: Respiratory medicine and research
https://read.qxmd.com/read/36608905/immune-cell-profiles-and-patient-clustering-in-complex-cases-of-interstitial-lung-disease
#34
JOURNAL ARTICLE
Alexandra van der Staal, Janett Göhring, Anna Ohradanova-Repic, Markus Kramer, Clemens Donner, Andreas Zech, Marco Idzko, Hannes Stockinger
Interstitial lung disease comprises numerous clinical entities posing significant challenges towards a prompt and accurate diagnosis. Amongst the contributing factors are intricate pathophysiological mechanisms, an overlap between conditions, and interobserver disagreement. We developed a model for patient clustering offering an additional approach to such complex clinical cases. The model is based on surface phenotyping of over 40 markers on immune cells isolated from bronchoalveolar lavage in combination with clinical data...
January 3, 2023: Immunology Letters
https://read.qxmd.com/read/36495695/inhibition-of-neutrophil-elastase-prevents-cigarette-smoke-exposure-induced-formation-of-neutrophil-extracellular-traps-and-improves-lung-function-in-a-mouse-model-of-chronic-obstructive-pulmonary-disease
#35
JOURNAL ARTICLE
Ke Wang, Yue Liao, Xiaoou Li, Ran Wang, Zijian Zeng, Mengxin Cheng, Lijuan Gao, Dan Xu, Fuqiang Wen, Tao Wang, Jun Chen
Chronic obstructive pulmonary disease (COPD) is an important public health challenge worldwide, and is usually caused by significant exposure to noxious agents, particularly cigarette smoke. Recent studies have revealed that excessive production of neutrophil extracellular traps (NETs) in the airways is associated with disease severity in COPD patients. NETs are extracellular neutrophil-derived structures composed of chromatin fibers decorated with histones and granule proteases including neutrophil elastase (NE)...
December 7, 2022: International Immunopharmacology
https://read.qxmd.com/read/36445126/combination-of-cefditoren-and-n-acetyl-l-cysteine-shows-a-synergistic-effect-against-multidrug-resistant-streptococcus-pneumoniae-biofilms
#36
JOURNAL ARTICLE
Mirella Llamosí, Julio Sempere, Pilar Coronel, Mercedes Gimeno, Jose Yuste, Mirian Domenech
Biofilm formation by Streptococcus pneumoniae is associated with colonization of the upper respiratory tract, including the carrier state, and with chronic respiratory infections in patients suffering from chronic obstructive pulmonary disease (COPD). The use of antibiotics alone to treat recalcitrant infections caused by biofilms is insufficient in many cases, requiring novel strategies based on a combination of antibiotics with other agents, including antibodies, enzybiotics, and antioxidants. In this work, we demonstrate that the third-generation oral cephalosporin cefditoren (CDN) and the antioxidant N -acetyl-l-cysteine (NAC) are synergistic against pneumococcal biofilms...
November 29, 2022: Microbiology Spectrum
https://read.qxmd.com/read/36394807/effect-of-tlr3-dsrna-complex-inhibitor-on-poly-i-c-induced-airway-inflammation-in-swiss-albino-mice
#37
JOURNAL ARTICLE
Swamita Arora, Sangeetha Gupta, Wasim Akram, Ahmed E Altyar, Priti Tagde
Rhinovirus infection frequently causes COPD and asthma exacerbations. Impaired anti-viral signaling and reduced viral clearance have both been seen in sick bronchial epithelium, potentially increasing exacerbations. Polyinosinic:polycytidylic acid (Poly(I:C)), a Toll-like receptor-3 (TLR3) ligand, has been shown to cause a viral exacerbation of severe asthma by detecting double-stranded RNA (dsRNA). The purpose of this work was to determine the effect of a TLR3/dsRNA complex inhibitor-Calbiochem drug in the prevention of Poly(I:C)-induced airway inflammation following TLR3 activation and to uncover a potential pathway for the cure of asthma through TLR3 inhibition...
February 2023: Environmental Science and Pollution Research International
https://read.qxmd.com/read/36317184/effectiveness-of-hospital-pharmacist-interventions-for-copd-patients-a-systematic-literature-review-and-logic-model
#38
REVIEW
Guohua Lin, Jiaqi Zheng, Pou Kuan Tang, Yu Zheng, Hao Hu, Carolina Oi Lam Ung
Purpose: This review aimed to summarize empirical evidence about pharmacist-led interventions for chronic obstructive pulmonary disease (COPD) patients in hospital settings and to identify the components of a logic model (including input, interventions, output, outcome and contextual factors) to inform the development of hospital pharmacist's role in COPD management. Methods: A systematic review of literature retrieved from four English databases (PubMed, Web of Science, Scopus, ScienceDirect) and one Chinese database (CNKI) were conducted to identify eligible studies published from inception to March 2022...
2022: International Journal of Chronic Obstructive Pulmonary Disease
https://read.qxmd.com/read/36304166/integrating-network-pharmacology-and-experimental-verification-to-decipher-the-immunomodulatory-effect-of-bu-zhong-yi-qi-tang-against-poly-i-c-induced-pulmonary-inflammation
#39
JOURNAL ARTICLE
Liufang Hu, Marina Yamamoto, Jiali Chen, Huifang Duan, Jing Du, Liangliang He, Danfeng Shi, Xinsheng Yao, Takayuki Nagai, Hiroaki Kiyohara, Zhihong Yao
Pulmonary inflammation caused by respiratory tract viral infections is usually associated with acute exacerbation of respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). Therefore, maintaining the pulmonary immune homeostasis is particular important for prevention of the acute exacerbation. Bu-Zhong-Yi-Qi-Tang (BZYQT), a traditional Chinese medicine formula, has been broadly used to improve respiratory and gastrointestinal disorders in China for over 700 years. Previously, we have found the regulatory activity of BZYQT on the lower respiratory immune system, while its potential effects during pulmonary inflammation remain unknown...
2022: Frontiers in Pharmacology
https://read.qxmd.com/read/36127649/artificial-intelligence-to-differentiate-asthma-from-copd-in-medico-administrative-databases
#40
JOURNAL ARTICLE
Hassan Joumaa, Raphaël Sigogne, Milka Maravic, Lucas Perray, Arnaud Bourdin, Nicolas Roche
INTRODUCTION: Discriminating asthma from chronic obstructive pulmonary disease (COPD) using medico-administrative databases is challenging but necessary for medico-economic analyses focusing on respiratory diseases. Artificial intelligence (AI) may improve dedicated algorithms. OBJECTIVES: To assess performance of different AI-based approaches to distinguish asthmatics from COPD patients in medico-administrative databases where the clinical diagnosis is absent. An "Asthma COPD Overlap" category was defined to further test whether AI can detect complexity...
September 20, 2022: BMC Pulmonary Medicine
keyword
keyword
67412
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.